http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2544287-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_753f4737e07b8a621c559df730f1d910 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28 |
| filingDate | 2013-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d82ac933c6c727699d4a72213241efe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6567fbb566039ae347090438a109aa45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_859814a7acd9ded352fc79b49dac7992 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed5392e16f590586db3969f9af0ca84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60c65e373e089caf8d8a2b6f05d8b044 |
| publicationDate | 2015-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2544287-C2 |
| titleOfInvention | Method for simulating cytomegalovirus infection in individual for studying and testing antiviral compounds and transplant for implementing it |
| abstract | FIELD: medicine. n SUBSTANCE: group of inventions refers to medicine and virology and concerns developing methods for creating a biological model of cytomegalovirus infection in an individual. One of the versions of the method involves implanting (grafting) of an implant representing a biodegradable matrix into immunodeficient nude mice. The implant is collagen sponge, or a matrix of chitosan, or polylactide matrix. The matrix involves proliferating, virus high-sensitive, normal, viable human cells pre-infected with human cytomegalovirus. The other version involves grafting of the same implant into the mice. The infection is implemented by administering human cytomegalovirus into the pre-grafted implant to the mice. n EFFECT: methods provide simulating the infections applicable to study its pathogenesis in the macroorganism, as well as to examine in vivo the antiviral action of the agents possessing the anti-CMV activity. n 3 cl, 4 dwg, 6 ex |
| priorityDate | 2013-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 306.